BAY59-7939 Japanese in Atrial Fibrillation (2nd)

NCT00973323 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Xarelto (Rivaroxaban, BAY59-7939)
DRUG: Xarelto (Rivaroxaban, BAY59-7939)
DRUG: Xarelto (Rivaroxaban, BAY59-7939)
DRUG: Warfarin

Sponsor

Bayer